Clinical implications of near-infrared fluorescence imaging in cancer.

Near-infrared (NIR) fluorescence cancer imaging is a growing field for both preclinical and clinical application to the clinical management for cancer patients due to its advantageous features, including a high spatial resolution, portability, real-time display and detailed molecular profiling with the multiplexed use of fluorescent probes. In this review, we present a basic concept of NIR fluorescence imaging and overview its potential clinical applications for in vivo cancer imaging, including cancer detection/characterization, lymphatic imaging (sentinel lymph node detection) and surgical/endoscopic guidance. NIR fluorescence imaging can compensate some limitations of conventional imaging modalities, and thus it could play an important role for cancer imaging combined with other modalities in clinical practice.

[1]  R. Weissleder,et al.  Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging , 2002, European Radiology.

[2]  R Weissleder,et al.  Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. , 2001, Radiology.

[3]  Osamu Ishikawa,et al.  A novel image‐guided surgery of hepatocellular carcinoma by indocyanine green fluorescence imaging navigation , 2009, Journal of surgical oncology.

[4]  Mitsuharu Miwa,et al.  Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer , 2005, Breast cancer.

[5]  R. Weissleder,et al.  Near infrared thoracoscopy of tumoral protease activity for improved detection of peripheral lung cancer , 2006, International journal of cancer.

[6]  S. Achilefu.  Lighting up Tumors with Receptor-Specific Optical Molecular Probes , 2004, Technology in cancer research & treatment.

[7]  M M Haglund,et al.  Enhanced optical imaging of human gliomas and tumor margins. , 1996, Neurosurgery.

[8]  G. Silvestri,et al.  Bronchoscopy for the diagnosis and staging of lung cancer. , 2008, Seminars in respiratory and critical care medicine.

[9]  Alexander M. Seifalian,et al.  Clinical Potential of Quantum Dots , 2008, Journal of biomedicine & biotechnology.

[10]  Shimon Weiss,et al.  Advances in fluorescence imaging with quantum dot bio-probes. , 2006, Biomaterials.

[11]  Jiwei Huang,et al.  Fabrication of indocyanine green encapsulated biodegradable microbubbles for structural and functional imaging of cancer. , 2009, Journal of biomedical optics.

[12]  Tristan Barrett,et al.  In vivo Diagnosis of Epidermal Growth Factor Receptor Expression using Molecular Imaging with a Cocktail of Optically Labeled Monoclonal Antibodies , 2007, Clinical Cancer Research.

[13]  Masato Yasuhara,et al.  Physicochemical Properties and Cellular Toxicity of Nanocrystal Quantum Dots Depend on Their Surface Modification , 2004 .

[14]  R. C. Benson,et al.  Fluorescence properties of indocyanine green as related to angiography. , 1978, Physics in medicine and biology.

[15]  Hisataka Kobayashi,et al.  A Self-Quenched Galactosamine-Serum Albumin-RhodamineX Conjugate: A “Smart” Fluorescent Molecular Imaging Probe Synthesized with Clinically Applicable Material for Detecting Peritoneal Ovarian Cancer Metastases , 2007, Clinical Cancer Research.

[16]  Bernhard Brendel,et al.  Diffuse optical tomography of the breast: preliminary findings of a new prototype and comparison with magnetic resonance imaging , 2009, European Radiology.

[17]  A Paul Alivisatos,et al.  Cellular effect of high doses of silica-coated quantum dot profiled with high throughput gene expression analysis and high content cellomics measurements. , 2006, Nano letters.

[18]  R. Weissleder,et al.  Imaging of differential protease expression in breast cancers for detection of aggressive tumor phenotypes. , 2002, Radiology.

[19]  Ralph Weissleder,et al.  Improved detection of ovarian cancer metastases by intraoperative quantitative fluorescence protease imaging in a pre-clinical model. , 2009, Gynecologic oncology.

[20]  P. Choyke,et al.  In vivo target-specific activatable near-infrared optical labeling of humanized monoclonal antibodies , 2009, Molecular Cancer Therapeutics.

[21]  John V Frangioni,et al.  New technologies for human cancer imaging. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  X. Intes.  Time-domain optical mammography SoftScan: initial results. , 2005, Academic radiology.

[23]  B. Ballou.  Quantum dot surfaces for use in vivo and in vitro. , 2005, Current topics in developmental biology.

[24]  S. Bhatia,et al.  Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.

[25]  S. Achilefu,et al.  Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. , 2000, Investigative radiology.

[26]  P. Choyke,et al.  Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremity , 2007, Breast Cancer Research and Treatment.

[27]  John V Frangioni,et al.  Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. , 2005, The Annals of thoracic surgery.

[28]  R. Weissleder,et al.  In vivo imaging of tumors with protease-activated near-infrared fluorescent probes , 1999, Nature Biotechnology.

[29]  K. Okamoto,et al.  Principle and clinical usefulness of the infrared fluorescence endoscopy , 2004, The Second Asian and Pacific Rim Symposium on Biophotonics, 2004. APBP 2004..

[30]  Hak Soo Choi,et al.  Real-time intraoperative ureteral guidance using invisible near-infrared fluorescence. , 2007, The Journal of urology.

[31]  S. Achilefu,et al.  Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor-targeted dye-peptide conjugate platform. , 2001, Journal of biomedical optics.

[32]  L. Cohn,et al.  Sentinel Lymph Node Mapping of the Gastrointestinal Tract by Using Invisible Light , 2006, Annals of Surgical Oncology.

[33]  Sanjiv S Gambhir,et al.  Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. , 2006, Nano letters.

[34]  W Semmler,et al.  Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes. , 2001, Bioconjugate chemistry.

[35]  Milton V. Marshall,et al.  Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. , 2008, Radiology.

[36]  M. Fujiwara,et al.  Sentinel lymph node detection in skin cancer patients using real-time fluorescence navigation with indocyanine green: preliminary experience. , 2009, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[37]  M. Bawendi,et al.  Engineering InAs(x)P(1-x)/InP/ZnSe III-V alloyed core/shell quantum dots for the near-infrared. , 2005, Journal of the American Chemical Society.

[38]  Aya Nakagawa,et al.  Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. , 2008, American journal of surgery.

[39]  P. Choyke,et al.  H-type dimer formation of fluorophores: a mechanism for activatable, in vivo optical molecular imaging. , 2009, ACS chemical biology.

[40]  M M Haglund,et al.  Enhanced optical imaging of rat gliomas and tumor margins. , 1994, Neurosurgery.

[41]  W. Semmler,et al.  Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands , 2001, Nature Biotechnology.

[42]  Jens Schneider-Mergener,et al.  A complete substitutional analysis of VIP for better tumor imaging properties , 2002, Journal of molecular recognition : JMR.

[43]  Tristan Barrett,et al.  In vivo molecular imaging to diagnose and subtype tumors through receptor-targeted optically labeled monoclonal antibodies. , 2007, Neoplasia.

[44]  Ralph Weissleder,et al.  Colonic adenocarcinomas: near-infrared microcatheter imaging of smart probes for early detection--study in mice. , 2007, Radiology.

[45]  M. Bawendi,et al.  Renal clearance of quantum dots , 2007, Nature Biotechnology.

[46]  T. Mihaljevic,et al.  Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping , 2004, Nature Biotechnology.

[47]  Michael R Hamblin,et al.  Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. , 2001, Cancer research.

[48]  Shimon Weiss,et al.  Quantum Dots for In Vivo Small-Animal Imaging , 2009, Journal of Nuclear Medicine.

[49]  Chun Li,et al.  Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. , 2003, Cancer research.

[50]  Soren D. Konecky,et al.  Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. , 2005, Medical physics.

[51]  Hisataka Kobayashi,et al.  Two-color lymphatic mapping using Ig-conjugated near infrared optical probes. , 2007, The Journal of investigative dermatology.

[52]  H. Grossman,et al.  Fluorescence cystoscopy: is it ready for use in routine clinical practice? , 2006, Current opinion in urology.

[53]  Vishal Saxena,et al.  Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. , 2004, Journal of photochemistry and photobiology. B, Biology.

[54]  J. Schneider-Mergener,et al.  Cyanine Dye Labeled Vasoactive Intestinal Peptide and Somatostatin Analog for Optical Detection of Gastroenteropancreatic Tumors , 2000, Annals of the New York Academy of Sciences.

[55]  Ralph Weissleder,et al.  Near-infrared optical imaging of proteases in cancer. , 2003, Molecular cancer therapeutics.

[56]  X. Intes.  Time-Domain Optical Mammography SoftScan , 2005 .

[57]  Hak Soo Choi,et al.  Image-Guided Oncologic Surgery Using Invisible Light: Completed Pre-Clinical Development for Sentinel Lymph Node Mapping , 2006, Annals of Surgical Oncology.

[58]  Jennifer J. Gibson,et al.  Electromagnetic breast imaging: results of a pilot study in women with abnormal mammograms. , 2007, Radiology.

[59]  R. Weissleder,et al.  Imaging in the era of molecular oncology , 2008, Nature.

[60]  John V. Frangioni,et al.  Organic Alternatives to Quantum Dots for Intraoperative Near-Infrared Fluorescent Sentinel Lymph Node Mapping , 2005, Molecular imaging.

[61]  David A Boas,et al.  Assessing the future of diffuse optical imaging technologies for breast cancer management. , 2008, Medical physics.

[62]  Hisataka Kobayashi,et al.  In vivo molecular imaging of cancer with a quenching near-infrared fluorescent probe using conjugates of monoclonal antibodies and indocyanine green. , 2009, Cancer research.

[63]  Sung Ju Cho,et al.  Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. , 2005, Chemistry & biology.

[64]  Tristan Barrett,et al.  Selective molecular imaging of viable cancer cells with pH-activatable fluorescence probes , 2009, Nature Medicine.

[65]  Tristan Barrett,et al.  Simultaneous multicolor imaging of five different lymphatic basins using quantum dots. , 2007, Nano letters.

[66]  Flower Rw,et al.  Indocyanine green dye fluorescence and infrared absorption choroidal angiography performed simultaneously with fluorescein angiography. , 1976 .

[67]  Heidrun Wabnitz,et al.  Scanning Time-domain Optical Mammography: Detection and Characterization of Breast Tumors In Vivo , 2005, Technology in cancer research & treatment.

[68]  Hisataka Kobayashi,et al.  Fluorophore-quencher based activatable targeted optical probes for detecting in vivo cancer metastases. , 2009, Molecular pharmaceutics.

[69]  Vasilis Ntziachristos,et al.  Looking and listening to light: the evolution of whole-body photonic imaging , 2005, Nature Biotechnology.

[70]  Stavros G Demos,et al.  Near-infrared autofluorescence imaging for detection of cancer. , 2004, Journal of biomedical optics.

[71]  Jan Grimm,et al.  A spatially and temporally restricted mouse model of soft tissue sarcoma , 2007, Nature Medicine.

[72]  V. Ntziachristos,et al.  Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[73]  P. Choyke,et al.  Imaging of the lymphatic system: new horizons. , 2006, Contrast media & molecular imaging.

[74]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[75]  R Brancato,et al.  Fluorescein and indocyanine green angiography in vascular chorioretinal diseases. , 1998, Seminars in ophthalmology.

[76]  Hak Soo Choi,et al.  Real-time intraoperative assessment of the extrahepatic bile ducts in rats and pigs using invisible near-infrared fluorescent light. , 2008, Surgery.

[77]  H. Bergh,et al.  Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. , 1994, Cancer research.

[78]  Tim Liedl,et al.  Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. , 2005, Nano letters.

[79]  Tristan Barrett,et al.  Multimodal nanoprobes for radionuclide and five-color near-infrared optical lymphatic imaging. , 2007, ACS nano.

[80]  Robert M. Hoffman,et al.  The multiple uses of fluorescent proteins to visualize cancer in vivo , 2005, Nature Reviews Cancer.

[81]  H. Honda,et al.  Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen antibody with an infrared fluorescence endoscope in vitro. , 2001, Endoscopy.